Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Fougera Pharmaceuticals Inc.

    Client Virtual Booth

    FOUGERA PHARMACEUTICALS INC.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Fougera Pharmaceuticals Inc.
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Alembic gets USFDA nod for ointment to treat skin disease
    Alembic gets USFDA nod for ointment to treat skin disease

    https://www.moneycontrol.com/news/business/alembic-gets-usfda-nod-for-ointment-to-treat-skin-disease-4556861.html

    MONEYCONTROL
    21 Oct 2019
    Share Share
    Fougera Pharms's Generic Tazarotene Receives Approval in US
    Fougera Pharms's Generic Tazarotene Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211175

    FDA
    28 Jan 2019
    Share Share
    Enforcement Report - Week of March 29, 2017
    Enforcement Report - Week of March 29, 2017

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-March-29-2017-1490767993.pdf

    FDA
    29 Mar 2017
    Share Share
    Slayback announces the final approval & launch of Generic Zovirax Ointment 5%
    Slayback announces the final approval & launch of Generic Zovirax Ointment 5%

    http://www.prnewswire.com/news-releases/slayback-pharma-announces-the-final-approval-and-launch-of-generic-zovirax-acyclovir-ointment-5-300383519.html

    PR NEWSWIRE
    27 Dec 2016
    Share Share
    Fougera Pharms Inc's Generic Acyclovir approved in US as an antiviral medication
    Fougera Pharms Inc's Generic Acyclovir approved in US as an antiviral medication

    https://www.pharmacompass.com/pdf/news/fougera-pharms-incs-generic-acyclovir-approved-in-us-as-an-antiviral-medication-1463220400.pdf

    FDA
    11 May 2016
    Share Share
    Novartis consolidating NY dermatology sites but says no jobs at risk
    Novartis consolidating NY dermatology sites but says no jobs at risk

    http://www.in-pharmatechnologist.com/Processing/Novartis-consolidating-NY-dermatology-sites-but-says-no-jobs-at-risk

    Dan Stanton+ IN PHARMATECHNOLOGIST
    10 Mar 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search